Tuberculosis drug resistance: a global threat.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12516027.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began. After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem. MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas. An understanding of the molecular basis of drug resistance may contribute to the development of new drugs. Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.
Medical subject headings
- Antitubercular Agents
- Drug Resistance, Bacterial
- Drug Resistance, Multiple
- Tuberculosis